Adam Koppel Insider Trading $TRVN TREVENA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Adam Koppel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Adam Koppel. Adam Koppel is EVP, Strategy and Bus. Dev. in BIOGEN INC. ($IDPH) and SVP, Chief Strategy Officer in BIOGEN INC. ($IDPH) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in TREVENA INC ($TRVN) and Director in Aptinyx Inc. ($APTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).

Adam Koppel in TREVENA INC

Trading Symbol: TRVN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Adam Koppel: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 17 2018
$TRVN Market Capitalization: $406.64M
$TRVN Previous Close: $7.85

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Adam Koppel in TREVENA INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, APTX, IDPH, CERE, DRNA, PTCT, SLDB, TRVN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 17 2018TRVNTREVENA INCKoppel AdamDirectorOption ExerciseA1.8430,00055,20030,000
Jun 06 2017TRVNTREVENA INCKoppel AdamDirectorOption ExerciseA3.0815,00046,20015,000
May 19 2016TRVNTREVENA INCKoppel AdamDirectorOption ExerciseA6.9815,000104,70015,000
May 21 2015TRVNTREVENA INCKoppel AdamDirectorOption ExerciseA6.808,87060,3168,870

Page:   1